EP 1984004 A2 20081029 - THERAPY-ENHANCING GLUCAN
Title (en)
THERAPY-ENHANCING GLUCAN
Title (de)
DIE THERAPIE VERSTÄRKENDES GLUCAN
Title (fr)
GLUCANE PERMETTANT D'AMÉLIORER UNE THÉRAPIE
Publication
Application
Priority
- US 2007001427 W 20070117
- US 33476306 A 20060117
Abstract (en)
[origin: WO2007084661A2] A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic composition may further comprise antitumor antibodies or cancer vaccine composition, wherein the antitumor activitiesof the antitumor antibodies or the cancer vaccine composition are enhanced by the yeast glucan.
IPC 8 full level
A61K 31/715 (2006.01)
CPC (source: EP US)
A61K 31/716 (2013.01 - EP); A61K 39/0011 (2013.01 - EP US); A61K 39/001106 (2018.08 - EP US); A61K 39/001113 (2018.08 - EP US); A61K 39/001124 (2018.08 - EP US); A61K 39/001129 (2018.08 - EP US); A61K 39/001171 (2018.08 - EP US); A61K 39/39 (2013.01 - EP); A61K 39/39558 (2013.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/02 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07K 16/3084 (2013.01 - EP); C08L 5/00 (2013.01 - EP); A61K 2039/542 (2013.01 - EP); A61K 2039/55511 (2013.01 - EP); A61K 2039/55583 (2013.01 - EP)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007084661 A2 20070726; WO 2007084661 A3 20071108; WO 2007084661 B1 20080110; AU 2008207369 A1 20080911; AU 2008207369 B2 20091217; EP 1984004 A2 20081029; EP 1984004 A4 20100303; JP 2009528267 A 20090806
DOCDB simple family (application)
US 2007001427 W 20070117; AU 2008207369 A 20080818; EP 07718218 A 20070117; JP 2008551413 A 20070117